Contribute to Compassionate Use Outcomes Database

About 1,200 compassionate use requests are submitted to FDA annually, but how many never reached FDA because they were denied by a drug company? What other barriers to obtaining an investigational drug are there? To develop effective compassionate use policies, it is necessary to understand the unmet need. We want to hear about your experiences with compassionate use applications, whether for a cancer patient or for another indication. Thank you.

I am a*
- patient
- caregiver / guardian / parent
- physician
Email*
Patient's initials*
Patient's age at time of application for compassionate use
Patient's gender
- Male
- Female
Type of cancer, stage, and diagnosis
Was the patient being treated at a comprehensive cancer center with the compassionate use request was submitted?
- Yes
- No
- Not sure
Name of the drug
Name of the pharmaceutical company
Name of a contact person at the company and contact information if known
How many days did it take for the drug company to respond?
Was the compassionate use request granted by the company? If not, reasons for denial?
Was the compassionate use request authorized by the FDA?
In the opinion of the treating physician, was the drug beneficial?
Where there unexpected toxicities or adverse events attributed to the drug? If yes, please explain briefly
Do you have any comments on your experience with the compassionate use application process?
Are you willing to briefly discuss your compassionate use application case is more detail? Please provide us with the best way to contact you.

Contribute to Our Outcomes Database

Thank you for contributing to our database!